Bouza E, Burillo A, Muñoz P. How to manage skin and soft-tissue infections in the emergency department. Curr Opin Infect Dis. 2023;36(2):81–8.
Google Scholar
Grossi AP, Ruggieri A, Vecchio A, Del Comandini A, Corio L, Calisti F, et al. Skin infections in Europe: a retrospective study of incidence, patient characteristics and practice patterns. Int J Antimicrob Agents. 2022;60(3):106637.
Google Scholar
Peterson RA, Polgreen LA, Cavanaugh JE, Polgreen PM. Increasing Incidence, Cost, and seasonality in patients hospitalized for cellulitis. Open Forum Infect Dis. 2017 Feb 8;4(1)ofx008.
Kaye KS, Petty LA, Shorr AF, Zilberberg MD. Current Epidemiology, Etiology, and burden of acute skin infections in the united States. Clin Infect Dis. 2019;68(Supplement3):S193–9.
Google Scholar
Falcone M, Tiseo G. Skin and soft tissue infections in the elderly. Curr Opin Infect Dis. 2023;36(2):102–8.
Google Scholar
Adly M, Woo TE, Traboulsi D, Klassen D, Hardin J. Understanding dermatologic concerns among persons experiencing homelessness: a scoping review and discussion for improved delivery of care. J Cutan Med Surg. 2021;25(6):616–26.
Google Scholar
Dellsperger S, Kramer S, Stoller M, Burger A, Geissbühler E, Amsler I, et al. Early switch from intravenous to oral antibiotics in skin and soft tissue infections: an algorithm-based prospective multicenter pilot trial. Open Forum Infect Dis. 2022;9(7):ofac197.
Google Scholar
Mohammed SA, Roberts JA, Cotta MO, Rogers B, Pollard J, Assefa GM, et al. Safety and efficacy of outpatient parenteral antimicrobial therapy: a systematic review and meta-analysis of randomized clinical trials. Int J Antimicrob Agents. 2024;64(2):107263.
Google Scholar
Tran TT, Gomez Villegas S, Aitken SL, Butler-Wu SM, Soriano A, Werth BJ et al. New perspectives on antimicrobial agents: Long-Acting lipoglycopeptides. Antimicrob Agents Chemother. 2022 Jun 21;66(6)(6):e0261420.
Hazen A, Pizzicato L, Hom J, Johnson C, Viner KM. Association between discharges against medical advice and readmission in patients treated for drug injection-related skin and soft tissue infections. J Subst Abuse Treat. 2021;126:108465.
Google Scholar
Carratalà J, Rosón B, Fernández-Sabé N, Shaw E, del Rio O, Rivera A, et al. Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis. Eur J Clin Microbiol Infect Dis. 2003;22(3):151–7.
Google Scholar
Macía-Rodríguez C, Alende-Castro V, Vazquez-Ledo L, Novo-Veleiro I, González-Quintela A. Skin and soft-tissue infections: factors associated with mortality and re-admissions. Enferm Infecc Microbiol Clin. 2017;35(2):76–81.
Google Scholar
Talan D, Salhi B, Moran G, Mower W, Hsieh YH, Krishnadasan A, et al. Factors associated with the decision to hospitalize emergency department patients with a skin and soft tissue infection. West J Emerg Med. 2015;16(1):89–97.
Google Scholar
Cieri B, Conway EL, Sellick JA, Mergenhagen KA. Identification of risk factors for failure in patients with skin and soft tissue infections. Am J Emerg Med. 2019;37(1):48–52.
Google Scholar
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.
Google Scholar
Jones AE, Trzeciak S, Kline JA. The sequential organ failure assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation*. Crit Care Med. 2009;37(5):1649–54.
Google Scholar
Rhee JY, Kwon KT, Ki HK, Shin SY, Jung DS, Chung DR, et al. Scoring systems for prediction of mortality in patients with intensive care unit-acquired sepsis. Shock. 2009;31(2):146–50.
Google Scholar
Guidance for industry acute bacterial skin and skin structure infections: Developing drugs for treatment. 2013. Available from: https://www.fda.gov/drugs/guidance-compliance-regulatory-information/guidances-drugs. Cited 2 Aug 2024.
Parra Caballero P, Pérez Esteban S, Patiño Ruiz ME, Castañeda Sanz S, García Vadillo JA. Actualización en fascitis necrotizante. Seminarios de la Fundación Española de Reumatología. 2012;13(2):41–8.
Google Scholar
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801.
Google Scholar
Barbier F, Timsit JF. Risk stratification for multidrug-resistant bacteria in patients with skin and soft tissue infection. Curr Opin Infect Dis. 2020;33(2):137–45.
Google Scholar
Keung EZ, Liu X, Nuzhad A, Adams C, Ashley SW, Askari R. Immunocompromised status in patients with necrotizing soft-tissue infection. JAMA Surg. 2013;148(5):419.
Google Scholar
The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 13.0. 2023. http://www.eucast.org.
Stevens DL et al. Clin Infect Dis (2014; 59:147–59). Clinical Infectious Diseases. 2015;60(9):1448–1448.
Abetz JW, Adams NG, Mitra B. Skin and soft tissue infection management failure in the emergency department observation unit: a systematic review. Emerg Med J. 2018;35(1):56–61.
Google Scholar
Blanes Hernández R, Rodríguez Pérez M, Fernández Navarro J, Salavert Lletí M. Current approach to skin and soft tissue infections. Thinking about continuity of care. Rev Esp Quimioter. 2023;36(Suppl1):37–45.
Google Scholar
Sartelli M, Guirao X, Hardcastle TC, Kluger Y, Boermeester MA, Raşa K, et al. 2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections. World J Emerg Surg. 2018;13(1):58.
Google Scholar
Cyriac JM, James E. Switch over from intravenous to oral therapy: a concise overview. J Pharmacol Pharmacother. 2014;5(2):83–7.
Google Scholar
Bookstaver PB, Jenkins TC, Stenehjem E, Doron S, Brown J, Goldwater SH et al. Impact of outpatient vs inpatient ABSSSI treatment on outcomes: A retrospective observational analysis of medical charts across US emergency departments. Open Forum Infect Dis. 2018 May 15;5(7)ofy109.
Claeys KC, Zasowski EJ, Lagnf AM, Sabagha N, Levine DP, Davis SL, et al. Development of a risk-scoring tool to determine appropriate level of care in acute bacterial skin and skin structure infections in an acute healthcare setting. Infect Dis Ther. 2018;7(4):495–507.
Google Scholar
Gonçalves-Bradley DC, Lannin NA, Clemson L, Cameron ID, Shepperd S. Discharge planning from hospital. Cochrane Database Syst Reviews. 2022 Feb 24;2(2):CD000313.
Larney S, Peacock A, Mathers BM, Hickman M, Degenhardt L. A systematic review of injecting-related injury and disease among people who inject drugs. Drug Alcohol Depend. 2017;171:39–49.
Google Scholar
Biancarelli DL, Biello KB, Childs E, Drainoni M, Salhaney P, Edeza A, et al. Strategies used by people who inject drugs to avoid stigma in healthcare settings. Drug Alcohol Depend. 2019;198:80–6.
Google Scholar
Langham FJ, Curtis SJ, Tang MJ, Jomon B, Doyle JS, Vujovic O, et al. Acute injection-related infections requiring hospitalisation among people who inject drugs: clinical features, microbiology and management. Drug Alcohol Rev. 2022;41(7):1543–53.
Google Scholar
Ti L, Ti L. Leaving the hospital against medical advice among people who use illicit drugs: a systematic review. Am J Public Health. 2015;105(12):e53-9.
Google Scholar
Dunne MW, Talbot GH, Boucher HW, Wilcox M, Puttagunta S. Safety of dalbavancin in the treatment of skin and skin structure infections: a pooled analysis of randomized, comparative studies. Drug Saf. 2016;39(2):147–57.
Google Scholar
Vazquez Deida AA, Shihadeh KC, Preslaski CR, Young HL, Wyles DL, Jenkins TC. Use of a standardized Dalbavancin approach to facilitate earlier hospital discharge for vulnerable patients receiving prolonged inpatient antibiotic therapy. Open Forum Infect Dis. 2020 Jul 13;7(8):ofaa293.
Williams DN, Baker CA, Kind AC, Sannes MR. The history and evolution of outpatient parenteral antibiotic therapy (OPAT). Int J Antimicrob Agents. 2015;46(3):307–12.
Google Scholar
Mirón-Rubio M, Parra Jordán JJ, González Ramallo VJ, Mujal Martínez A, Fernández Muixí J, Iglesias Gallego M, et al. Economic burden of skin and skin structure infections due to gram-positive bacteria in patients on hospital at home-based outpatient parenteral antibiotic therapy (OPAT). Rev Esp Quimioter. 2023;36(3):291–301.
Google Scholar
Chan M, Ooi CK, Wong J, Zhong L, Lye D. Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore. BMC Infect Dis. 2017;17(1):474.
Google Scholar
Seaton RA, Sharp E, Bezlyak V, Weir CJ. Factors associated with outcome and duration of therapy in outpatient parenteral antibiotic therapy (OPAT) patients with skin and soft-tissue infections. Int J Antimicrob Agents. 2011;38(3):243–8.
Google Scholar
Ong BS, Ngian VJJ, Yeong C, Keighley C.
Out Of Hospital And In Hospital Management Of Cellulitis Requiring Intravenous Therapy
. Int J Gen Med. 2019;12:447–53.
Huang V, Ruhe JJ, Lerner P, Fedorenko M. Risk factors for readmission in patients discharged with outpatient parenteral antimicrobial therapy: a retrospective cohort study. BMC Pharmacol Toxicol. 2018;19(1):50.
Google Scholar
Suzuki J, Johnson J, Montgomery M, Hayden M, Price C. Outpatient parenteral antimicrobial therapy among people who inject drugs: a review of the literature. Open Forum Infect Dis. 2018 Aug 7;5(9):ofy194.
Buehrle DJ, Shields RK, Shah N, Shoff C, Sheridan K. Risk factors associated with outpatient parenteral antibiotic therapy program failure among intravenous drug users. Open Forum Infect Dis. 2017 May 23;4(3)ofx102.
Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG, Fritsche TR. Contemporary causes of skin and soft tissue infections in North America, Latin America, and europe: report from the SENTRY antimicrobial surveillance program (1998–2004). Diagn Microbiol Infect Dis. 2007;57(1):7–13.
Google Scholar
Ray GT, Suaya JA, Baxter R. Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study. BMC Infect Dis. 2013;13(1):252.
Google Scholar
Vella V, Galgani I, Polito L, Arora AK, Creech CB, David MZ, et al. Staphylococcus aureus skin and soft tissue infection recurrence rates in outpatients: A retrospective database study at 3 US medical centers. Clin Infect Dis. 2021;73(5):e1045–53.
Google Scholar
Collazos J, de la Fuente B, García A, Gómez H, Menéndez C, Enríquez H, et al. Cellulitis in adult patients: a large, multicenter, observational, prospective study of 606 episodes and analysis of the factors related to the response to treatment. PLoS One. 2018;13(9):e0204036.
Google Scholar
Leme RCP, Bispo PJM, Salles MJ. Community-genotype methicillin-resistant Staphylococcus aureus skin and soft tissue infections in Latin America: a systematic review. Braz J Infect Dis. 2021;25(1):101539.
Google Scholar
Cucinotta D, Vanelli M WHO declares COVID-19 a pandemic.Acta Biomed. 2020; 91((1):):157–60.
Google Scholar
